CDC: 2012-2013 flu vaccine not as effective in elderly

CDC: 2012-2013 flu vaccine not as effective in elderly
Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Lisa Jackson, M.D., of the CDC in Atlanta, and colleagues analyzed data from the U.S. Influenza Vaccine Effectiveness Network to estimate vaccine effectiveness (VE) for the 2012/2013 influenza season.

The researchers estimated the overall VE against influenza A and B to be 47 and 67 percent, respectively, or 56 percent overall, which was close to the interim estimate of 62 percent. When stratified by age group, the estimates for VE against influenza A (H3N2) and B infections were mostly consistent across age groups, with the exception that lower VE against influenza A (H3N2) was seen among adults aged 65 and older. These findings suggest vaccination against influenza reduces the risk of illness requiring outpatient medical visits by one-half to two-thirds for most people, although VE was lower and not statistically significant among people aged 65 and older.

"Antiviral medications should be used as recommended for treatment of suspected influenza in certain patients, including those aged ≥65 years, regardless of their influenza vaccination status," the authors write.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

CDC: Influenza activity increasing across the U.S.

Jan 05, 2013

(HealthDay)—Flu season descended on the United States early and hard this winter, with significant increases in flu activity observed over the past month, according to an update issued Jan. 4 by the U.S. ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments